Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2. Currently, several strategies are being pursued to...

Full description

Bibliographic Details
Published in:	Pathogens
Main Authors:	Edris Shirvani, Siba K. Samal
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Subjects:	SARS-CoV-2 COVID-19 coronavirus Newcastle disease virus (NDV) vaccine viral vector and viral respiratory infection
Online Access:	https://www.mdpi.com/2076-0817/9/8/619

Similar Items

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
by: Shin-Hee Kim, et al.
Published: (2019-03-01)

Cloning of fusion protein gene of Newcastle disease virus into a baculovirus derived bacmid shuttle vector, in order to express it in insect cell line
by: Hashemzadeh MS, et al.
Published: (2015-05-01)

The interference of Newcastle, avian influenza and infectious bursal disease vaccines with the efficiency of IB vaccine in broiler chicks by using quantitative RT-PCR test
by: Raed Hussen Saleh, et al.
Published: (2019-04-01)

Phylogenetic and pathotypic characterization of newcastle disease virus in Tibetan chickens, China
by: Hongyun Zhu, et al.

Effect of associated vaccines on the interference between Newcastle disease virus and infectious bronchitis virus in broilers
by: WM Cardoso, et al.
Published: (2005-09-01)

Serological Detection of Newcastle Disease Virus Antibody in Vaccinated and Non-Vaccinated Indigenous Chickens and Guinea Fowls in Atacora and Donga, Northern Benin
by: Edmond Onidje, et al.
Published: (2024-10-01)

Development and Evaluation of a Newcastle Disease Virus-like Particle Vaccine Expressing SARS-CoV-2 Spike Protein with Protease-Resistant and Stability-Enhanced Modifications
by: Yu Chen, et al.
Published: (2024-12-01)

Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection
by: Deok-Hwan Kim, et al.
Published: (2024-08-01)

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
by: Weina Sun, et al.
Published: (2020-12-01)

Clinico-pathological assessment of virulent Newcastle Disease Virus in ducks
by: B. Zahid, et al.
Published: (2022-01-01)

Recombinant Newcastle virus rL-RVG inhibits proliferation of human lung adenocarcinoma cell lines
by: ZHANG Zhenzhen, LI Yang, GAO Shengbao, XIA Dexin, YAN Yulan
Published: (2023-10-01)

Genotype I Newcastle Disease Virus, Isolated from Wild Duck, Can Protect Chickens Against Newcastle Disease Caused by Genotype VII
by: Elizaveta Boravleva, et al.
Published: (2025-04-01)

Comparative studies on two tests for detection of avian influenza a virus and Newcastle disease virus in co-infected guinea fowl (Numida meleagris)
by: Iv. Zarkov
Published: (2018-03-01)

Adaptation of the Vaccine Prophylaxis Strategy to Variants of the SARS-CoV-2 Virus
by: Sofia M. Gulova, et al.
Published: (2025-07-01)

Analysis of Newcastle disease virus prevalence in wild birds reveals interhost transmission of genotype VI strains
by: Tingting Zeng, et al.
Published: (2024-12-01)

Designing and Evaluation of a Multiepitope Vaccine against Avian Newcastle Disease Virus, Influenza Virus and Infectious Bronchitis Virus
by: Morteza Ghandadi
Published: (2024-07-01)

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
by: Noemi García-Romero, et al.
Published: (2020-06-01)

The production of Newcastle disease virus-like particles in Nicotiana benthamiana as potential vaccines
by: Tanja Smith, et al.
Published: (2023-02-01)

Viral vector-based vaccines against SARS-CoV-2
by: Kenneth Lundstrom
Published: (2021-10-01)

Clinical Characteristics and Outcomes of Hospitalized AECOPDs Secondary to SARS-CoV-2 versus Other Respiratory Viruses
by: Chhor L, et al.
Published: (2024-11-01)

Potentiating effect of pidotimod on immune responses of chickens to live attenuated Newcastle disease vaccines
by: Ya-Li Li, et al.
Published: (2016-07-01)

Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques
by: Bryce M. Warner, et al.
Published: (2024-04-01)

Genetic Diversity of Newcastle Disease Virus Involved in the 2021 Outbreaks in Backyard Poultry Farms in Tanzania
by: Charlie F. Amoia, et al.
Published: (2023-07-01)

The effect of 5′ and 3′ non-translated regions on the expression of a transgene from a Newcastle disease virus vector
by: Ishita Roy Chowdhury, et al.
Published: (2024-03-01)

Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins
by: Scott Bachus, et al.
Published: (2022-04-01)

Optimization and Validation of Universal Real-Time RT-PCR Assay to Detect Virulent Newcastle Disease Viruses
by: Ellen Ruth Alexander Morris, et al.
Published: (2025-05-01)

SARS-CoV-2 in brief: from virus to prevention
by: Hassan Karami, et al.
Published: (2022-12-01)

A Novel Recombinant Newcastle Disease Vaccine Improves Post- <i>In Ovo</i> Vaccination Survival with Sustained Protection against Virulent Challenge
by: Valerie C. Marcano, et al.
Published: (2021-08-01)

The Validation of a Hemagglutination Inhibition Assay That Detects Antibodies Against a Newcastle Disease Virus-Based Vaccine Vector in Human Serum Samples
by: Milton Nieto-Ponce, et al.
Published: (2025-03-01)

The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy
by: Huiming Yang, et al.
Published: (2024-05-01)

The Combined Use of rHVT-H5 and rHVT-F Vector Vaccines in the Hatchery Enhances Immunity against Highly Pathogenic Avian Influenza H5N1 and Velogenic Newcastle Disease Viral Infections in Commercial Chickens
by: Abd El-Hamid HS, et al.
Published: (2018-12-01)

Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein
by: Xiaolong Lu, et al.
Published: (2023-10-01)

Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus
by: Chuanqi Yan, et al.
Published: (2020-07-01)

Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
by: Julia P. C. Fulber, et al.
Published: (2022-05-01)

Isolation and characterization of a recent Newcastle disease virus from infected backyard chickens in Egypt
by: Samir A. Nassif, et al.
Published: (2025-05-01)

A Novel SARS-CoV-2-Derived Infectious Vector System
by: Ghada Elfayres, et al.
Published: (2025-06-01)

Subgenotype VII.1.1 Newcastle Disease Virus Evolution and Spread in the Russian Federation in 2019–2023
by: Nelly A. Guseva, et al.
Published: (2025-09-01)

Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
by: Thomas M. McAusland, et al.
Published: (2021-03-01)

In Ovo evaluation of antiviral effects of aqueous garlic (Allium sativum) extract against a velogenic strain of Newcastle disease virus
by: Fatemeh Doostmohammadian, et al.
Published: (2020-07-01)

The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect
by: Bo-Kyoung Jung, et al.
Published: (2024-01-01)